CCL2 and central nervous system cancer: As expected, the IHC analysis showed that CCL2 was also upregulated in glioma tissues compared with normal tissues (Fig. 4E); the qPCR measurement showed the abundant expression of CCL2 in U87, U251, U373, and SHG-44 cells (Fig. 4F).